ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Are Drugs Becoming More Lipophilic Over Time?

  Get a deeper look into how drug lipophilicity has evolved over time, its impact on drug development, and the need for new technology to enable new more complex drugs.

• Why Connect An Auto-Injector To A Smartphone?

  Why would a person with diabetes want to link their auto-injector to the Internet? Given that smartphones are so central to our everyday lives, it could be argued that the better question is: Why not? 

• Taste Masking 101: Optimize Taste And Improve Patient Outcomes

  Taste masking is integral for a drug product’s final formulation. It can serve to increase patient acceptability and adherence to a therapy, in turn bolstering regulatory acceptance and commercial potential.

• 6 Strategic Pillars For Selecting A Drug Packaging Partner

  Early engagement with an expert packaging partner supports safe, cost-effective drug development and logistical success from precommercial stages through full market launch.

• Meeting The Growing Demand For Pre-Filled Syringes

  The market for pre-filled syringes is growing rapidly. Learn more about the benefits for consumers, providers, and manufacturers, and the importance of partnering with a reliable fill finish facility.

• Getting Ahead Of PFAS Risk In Pharmaceutical Manufacturing

  Pharma can’t simply eliminate essential PFAS uses. A phased, risk-based strategy can address footprint, exposure, and supply risks amid regulatory uncertainty.

• The Constraints And Innovations In The Packaging Of Biologic Drugs

  Biologic therapies require specialized packaging to prevent drug degradation. Discover how advanced primary containment systems overcome stability and delivery challenges for patient care.

• How MedTech And Pharma Are Responding To Rising R&D Pressures

  MedTech accelerates innovation through acquisition and integration while pharma sustains research depth by distributing risk and cost. These distinct paths are reshaping product development.

• Understanding Risks Of Biologic Drugs And Injectable Drug-Device Combination Products

  As the benefits of delivering biologic drugs as part of a combination product platform are realized, this self-administration trend will continue to grow. From a regulatory perspective, the use of a risk-based approach is foundational.

• Keys To Driving Consistent Quality In Contract Manufacturing

  Complex products and supply chains present plenty of opportunities for failure, especially when new products are being developed and launched. This article discusses key ingredients to robust and advanced quality planning that are essential to quality in contract manufacturing.